findmyKOL
Clinical trialNCT00493857TerminatedPhase 2Interventional

Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer

SponsorYM BioSciencesEnrollment100Colorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Tom Baker Cancer Center

    Calgary, Alberta, Canada

  • Cancer Care Manitoba

    Winnipeg, Manitoba, Canada

  • Dr. H. Bliss Purphy Cancer Centre

    St. John's, Newfoundland and Labrador, Canada

  • Royal Victoria Hospital

    Barrie, Ontario, Canada

  • Grand River Hospital

    Kitchener, Ontario, Canada

  • London Regional Cancer Centre

    London, Ontario, Canada

  • Credit Valley Hospital /carlo Fidani Peel Regional Cancer Centre

    Mississauga, Ontario, Canada

  • Cancer Care Program Southlake Regional Health Centre

    Newmarket, Ontario, Canada

  • Ottawa Regional Cancer Centre

    Ottawa, Ontario, Canada

  • Algoma District Cancer Care Program

    Sault Ste. Marie, Ontario, Canada

  • Princess Margaret Hospital

    Toronto, Ontario, Canada

  • Sunnybrook Regional Cancer Centre

    Toronto, Ontario, Canada

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2007
Primary completion
31 Aug 2008
Completion
31 Dec 2008
Last update posted
17 Nov 2008
Registered enrollment
100
Registry id
NCT00493857

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.